GSK wants consumers to kick the habit
MUMBAI, India The OTC division of a big drug maker hopes to reach almost 1 billion people worldwide with its anti-smoking products.
GlaxoSmithKline Consumer Healthcare announced Monday that it would increase the availability of its therapeutic nicotine products to 800 million people around the world over the next four years. It made the announcement at this year’s World Conference on Tobacco OR Health in India.
“GSK plans to introduce our quit-smoking aids to 85% of the world’s smokers by 2013,” said Raj Mishra, GSK Consumer Healthcare VP research and development. “We are committed to finding approaches, in concert with local experts, to maximize the access and impact of our life-saving products.”
A report by the World Health Organization found that tobacco use was increasingly most rapidly in poor countries due to steady population growth and tobacco industry efforts, and that without a commitment to helping smokers quit, 1 billion will die prematurely from tobacco in this century.
Watson, Elan Corp. settle patent infringement suit
CORONA, Calif. Generic drug maker Watson Pharmaceuticals has settled with Irish pharmaceutical and biotech company Elan Corp. concerning patent litigation surrounding Watson’s generic version of an Elan drug.
Under the terms of the agreement, Watson will pay Elan $18 million to settle disputes over the development, manufacturing, marketing and sale of its generic version of the pain drug Naprelan (naproxen sodium). Watson also agreed not to market or sell its version until the expiration of Elan’s patent for the drug, which will occur in 2014, according to the Food and Drug Administration’s Orange Book.
In August, the United States District Court for the Southern District of Florida ruled that Watson’s generic Naprelan infringed Elan’s ‘320 patent on the drug.
Centice launches a Web site dedicated to Pass Rx
MORRISVILLE, N.C. Centice Corporation has launched a Web site about its Pass Rx dispensing machine.
The company said it developed the site for pharmacists to learn about the Pass Rx system, including how to implement and use it.
“The launch of our new Web site will help get the word out about the availability and benefits of Pass Rx,” Centice president and CEO Ray Swanson said in a statement. “We are very excited to provide our customers with a new venue to learn more about Pass Rx and how the system can benefit their pharmacy by increasing their patients’ safety, improving the quality control process and overall workflow efficiency.”